These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2013-002112-27 Effect of MD1003 in chronic visual loss related to optic neuritis in multiple sclerosis: a pivotal randomized double masked placebo controlled study 2019-08-01 bad-data
Reported results 2013-002113-35 Effect of MD1003 in spinal progressive multiple sclerosis: a pivotal randomized double blind placebo controlled study MD1003 dans le traitement des formes progressives spinales de sclerose en plaqu... 2020-06-04 due-trials
Completed, but no date, and reported results 2014-000698-38 MD1003 IN ADRENOMYELONEUROPATHY: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY MD1003 en la adrenomieloneuropatía: un estudio aleatorizado con doble enmascaramiento controlado por placebo bad-data
Reported results 2015-001150-15 SERENDEM study: MD1003 in patients suffering from demyelinating neuropathies, an open label pilot study 2019-03-18 due-trials
Reported results 2015-005810-31 Effect of MD1003 in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled study 2018-05-24 due-trials
Reported results 2016-000700-29 Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study. 2020-05-05 due-trials